Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$30.12+1.82 (+6.43%)
Close on Nov 13, 2026Market cap $1.13BP/E –Yield –
Harrow profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Harrow's profit margin for the twelve months ending Sep 30, 2026 was -9.4%. For fiscal 2025 it was -1.9%, against -8.8% the year before. The highest annual figure on record is 35.3% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1.9% | +6.9 |
| FY2024 | Dec 31, 2024 | -8.8% | +10.0 |
| FY2023 | Dec 31, 2023 | -18.7% | −2.9 |
| FY2022 | Dec 31, 2022 | -15.9% | +8.9 |
| FY2021 | Dec 31, 2021 | -24.8% | −18.0 |
| FY2020 | Dec 31, 2020 | -6.9% | −7.2 |
| FY2019 | Dec 31, 2019 | 0.3% | −35.0 |
| FY2018 | Dec 31, 2018 | 35.3% | +80.1 |
| FY2017 | Dec 31, 2017 | -44.8% | +50.9 |
| FY2016 | Dec 31, 2016 | -95.7% | +67.9 |
| FY2015 | Dec 31, 2015 | -163.6% | +445.9 |
| FY2014 | Dec 31, 2014 | -609.5% | +75821.7 |
| FY2013 | Dec 31, 2013 | -76431.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 9.8% | +8.4 |
| Q2 FY2026 | Jun 30, 2026 | -24.4% | −32.3 |
| Q1 FY2026 | Mar 31, 2026 | -62.4% | −25.3 |
| Q4 FY2025 | Dec 31, 2025 | 7.4% | −2.7 |
| Q3 FY2025 | Sep 30, 2025 | 1.4% | +10.0 |
| Q2 FY2025 | Jun 30, 2025 | 7.8% | +21.1 |
| Q1 FY2025 | Mar 31, 2025 | -37.2% | +2.0 |
| Q4 FY2024 | Dec 31, 2024 | 10.1% | +35.3 |
| Q3 FY2024 | Sep 30, 2024 | -8.6% | +4.2 |
| Q2 FY2024 | Jun 30, 2024 | -13.2% | −0.6 |
| Q1 FY2024 | Mar 31, 2024 | -39.2% | −13.8 |
| Q4 FY2023 | Dec 31, 2023 | -25.2% | −30.4 |
| Q3 FY2023 | Sep 30, 2023 | -12.8% | +15.5 |
| Q2 FY2023 | Jun 30, 2023 | -12.6% | +14.1 |
| Q1 FY2023 | Mar 31, 2023 | -25.4% | −14.4 |
| Q4 FY2022 | Dec 31, 2022 | 5.2% | +41.9 |
| Q3 FY2022 | Sep 30, 2022 | -28.3% | +16.2 |
| Q2 FY2022 | Jun 30, 2022 | -26.8% | −13.1 |
| Q1 FY2022 | Mar 31, 2022 | -11.0% | −12.4 |
| Q4 FY2021 | Dec 31, 2021 | -36.7% | −44.6 |
| Q3 FY2021 | Sep 30, 2021 | -44.5% | −104.5 |
| Q2 FY2021 | Jun 30, 2021 | -13.7% | −10.7 |
| Q1 FY2021 | Mar 31, 2021 | 1.4% | +110.6 |
| Q4 FY2020 | Dec 31, 2020 | 7.9% | −13.2 |
| Q3 FY2020 | Sep 30, 2020 | 60.0% | +149.9 |
| Q2 FY2020 | Jun 30, 2020 | -2.9% | +14.7 |
| Q1 FY2020 | Mar 31, 2020 | -109.2% | −201.6 |
| Q4 FY2019 | Dec 31, 2019 | 21.1% | −138.2 |
| Q3 FY2019 | Sep 30, 2019 | -89.9% | −66.5 |
| Q2 FY2019 | Jun 30, 2019 | -17.6% | −41.9 |
| Q1 FY2019 | Mar 31, 2019 | 92.4% | +132.0 |
| Q4 FY2018 | Dec 31, 2018 | 159.3% | +197.0 |
| Q3 FY2018 | Sep 30, 2018 | -23.4% | +64.4 |
| Q2 FY2018 | Jun 30, 2018 | 24.3% | +2.6 |
| Q1 FY2018 | Mar 31, 2018 | -39.6% | +42.5 |
| Q4 FY2017 | Dec 31, 2017 | -37.8% | +67.6 |
| Q3 FY2017 | Sep 30, 2017 | -87.8% | – |
| Q2 FY2017 | Jun 30, 2017 | 21.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -82.1% | – |
| Q4 FY2016 | Dec 31, 2016 | -105.3% | – |
See a number that looks wrong?